·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
µ¶ÀÚÁ¦º¸
Event
´º½º
Àüü±â»ç
Á¤Ã¥ · ¹ý·ü
Á¦¾à · ¹ÙÀÌ¿À
¾à±¹ · º´¿ø
Ä«µå´º½º
ÆÊTV
À̽´¿µ»ó
ºÎÀۿ븮Æ÷Æ®
1µî ¾à±¹À» ã¾Æ¼
½ºÆ¿ÄÆ ¿µ»ó
¿ÀÇǴϾð
Àü¹®°¡Ä®·³
µ¥½ºÅ©½Ã¼±
±âÀÚÀÇ ´«
µ¶ÀÚ±â°í
English
Policy
Opinion
Company
Product
Interview
TVÆÊµµ¶ó
ÆÊTube
ÆÊ¼îÇÎ
³ª´Â¾à»ç´Ù
ÆÊµå¶ó¸¶
ÆÊ¾ÆÄ«µ¥¹Ì
Á¦Ç°°ÁÂ
Çмú°ÁÂ
°æ¿µ°ÁÂ
Ä¿¹Â´ÏƼ
ÆÊ¸®Äí¸£Æ®
ä¿ëÁ¤º¸
PHARMARCY
ÀÎÀçÁ¤º¸
DPºÎµ¿»ê
¾à±¹»ó´ã¼Ò
¾à±¹´ëÃâ
¼¼¹«»ó´ã
¹ý·ü»ó´ã
¾à±¹ÈÀåǰ
¾à±¹°æ¿µ
¾à»ç´ëÃâ
ÀǾàÀÚ·á½Ç
ÀǾàÇàÁ¤
¾à»ç¾à±¹
ÀǷẴ¿ø
Á¦¾àÀ¯Åë
º¸µµÀÚ·á
ÆÊÆ÷ÀÎÆ®¸ô
À¯¸Ó · ¸¸È
ÀÎ»ç · ºÎÀ½
¾à±¹ÀåÅÍ
ȸ»ç¼Ò°³
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
»ç¾÷Á¦ÈÞ
ÀÎÅͳݽŹ®À±¸®°·É
µ¶ÀÚÁ¦º¸
±âÀÚÀ±¸®°·É
ÀÚÀ²¼¾à¼
¿ø°ÝÁö¿ø¿äû
Event & ¼¼¹Ì³ª
Àüü±â»ç
±×·¡ÇÈ
Á¤Ã¥¡¤¹ý·ü
Á¦¾à¡¤¹ÙÀÌ¿À
¾à±¹¡¤º´¿ø
±âȹ¡¤Å½»ç
»ç¼³
Àü¹®°¡Ä®·³
µ¥½ºÅ©½Ã¼±
񃯇
񃯇
ÀǾàǰ
³¹¾Ë½Äº°
µ¥Àϸ®ÆÊ Live Search
´Ý±â
´º½º
>
Á¦¾à¹ÙÀÌ¿À
>
R&D¿Í ¾à¹°
FDA ¹®ÅÎ ³ÑÀº Áß±¹ ¸é¿ªÇ×¾ÏÁ¦...Çѱ¹Àº °ÉÀ½¸¶ ´Ü°è
2023-11-11 05:50:37
[µ¥Àϸ®ÆÊ=¼ÕÇü¹Î ±âÀÚ] Áß±¹ Á¦¾à»ç°¡ °³¹ßÇÑ ¸é¿ªÇ×¾ÏÁ¦°¡ ¾Æ½Ã¾Æ ÃÖÃÊ·Î ¹Ì±¹ Çã°¡ ¹®ÅÎÀ» ³ÑÀ¸¸é¼ ±¹»ê ¸é¿ªÇ×¾ÏÁ¦ÀÇ »ó¿ëÈ °¡´É¼º¿¡µµ À̸ñÀÌ ÁýÁߵȴÙ. ...
¼ÕÇü¹Î ±âÀÚ
"·º¶óÀÚ, ³úÀüÀÌ È¿°ú È®½Ç"¡¦ÇÏÀ§ºÐ¼®, JTO Àú³Î °ø°³
2023-11-10 21:04:58
[µ¥Àϸ®ÆÊ=³ëº´Ã¶ ±âÀÚ] ±Û·Î¹ú ÁøÃâÀ» ¸ñÀü¿¡ µÐ À¯ÇѾçÇàÀÇ ±¹»ê 3¼¼´ë EGFR º¯ÀÌ Ç¥ÀûÄ¡·áÁ¦ ·º¶óÀÚ(·¹ÀÌÀúƼ´Õ)°¡ ³úÀüÀÌ È¿°ú¶ó´Â °Á¡À» ´Ù½Ã±Ý ÀÔÁõÇß´Ù. ...
³ëº´Ã¶ ±âÀÚ
'Á¤¸Æ ´ë½Å ÇÇÇÏ·Î'¡¦¸é¿ªÇ×¾ÏÁ¦ Á¦Çü º¯°æ °æÀï °¡¿
2023-11-10 05:50:42
[µ¥Àϸ®ÆÊ=¼ÕÇü¹Î ±âÀÚ] ¸é¿ªÇ×¾ÏÁ¦¸¦ º¸À¯ÇÑ ±Û·Î¹ú Á¦¾à»çµéÀÇ ÇÇÇÏÁÖ»ç(SC) Á¦Çü °³¹ß °æÀïÀÌ Ä¡¿ÇÏ´Ù. ±âÁ¸ Ç×¾ÏÁ¦´Â ´ëºÎºÐ Á¤¸ÆÅõ¿©(IV) ¹æ½ÄÀε¥ Åõ¿© ½Ã°£...
¼ÕÇü¹Î ±âÀÚ
¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ±â¹Ý ³Ä¡¼º Áúȯ Ä¡·áÁ¦ °³¹ß Ȱ¹ß
2023-11-10 05:50:40
[µ¥Àϸ®ÆÊ=³ëº´Ã¶ ±âÀÚ] ¸¶ÀÌÅ©·Î¹ÙÀÌ¿ÈÀ» Ȱ¿ëÇÑ Ä¡·á¿µ¿ªÀÌ ´Ü¼ø ¼Òȱ⿡¼ ¸é¿ª¡¤Ç׾Ϻо߷Π¹üÀ§¸¦ ³ÐÇô°¡°í ÀÖ¾î ÁÖ¸ñµÈ´Ù. ÀÎü ¸¶ÀÌÅ©·Î¹ÙÀÌ¿ÈÀÇ ºÒ±ÕÇü...
³ëº´Ã¶ ±âÀÚ
ŰƮ·ç´Ù, ¹Ì±¹¼ ´ãµµ¾Ï Ä¡·á ½ÂÀΡ¦ÀûÀÀÁõ Ãß°¡ È®Àå
2023-11-09 05:50:23
[µ¥Àϸ®ÆÊ=¼ÕÇü¹Î ±âÀÚ] ¹Ì±¹¿¡¼ ŰƮ·ç´Ù(¼ººÐ¸í Æèºê·Ñ¸®ÁÖ¸¿)°¡ ´ãµµ¾Ï 1Â÷ Ä¡·á ÀûÀÀÁõÀ» Ãß°¡·Î È®º¸Çß´Ù. ÀÌ¿¡ ±¹³»¿¡¼µµ ŰƮ·ç´Ù°¡ ´ãµµ¾Ï 1Â÷ Ä¡·áÁ¦·Î...
¼ÕÇü¹Î ±âÀÚ
Æ®·Îµ¨ºñ, »ïÁßÀ½¼ºÀ¯¹æ¾Ï 2Â÷ Ç¥ÁØÄ¡·áÁ¦·Î µî±ØÇÒ±î
2023-11-07 17:19:07
[µ¥Àϸ®ÆÊ=¼ÕÇü¹Î ±âÀÚ] Ç×ü¾à¹°Á¢ÇÕü(Antibody Drug Conjugate, ADC) Ç×¾ÏÁ¦°¡ ±¹³» »ïÁßÀ½¼ºÀ¯¹æ¾Ï Ä¡·á ½ÃÀå¿¡ óÀ½ µîÀåÇß´Ù. ÇöÀç±îÁö´Â ¸é¿ªÇ×¾ÏÁ¦¿Í PARP...
¼ÕÇü¹Î ±âÀÚ
GIFT 1È£ '·é¼ö¹Ì¿À' Çã°¡¿Í µ¿½Ã¿¡ ±Þ¿© ½É»ç µ¹ÀÔ
2023-11-07 05:50:42
[µ¥Àϸ®ÆÊ=¾îÀ±È£ ±âÀÚ] ¸²ÇÁÁ¾ ½Å¾à ·é¼ö¹Ì¿À°¡ ±¹³» Çã°¡¿Í ÇÔ²² °ð¹Ù·Î º¸Çè±Þ¿© ½É»ç¿¡ µ¹ÀÔÇÑ´Ù. °ü·Ã ¾÷°è¿¡ µû¸£¸é Çѱ¹·Î½´ÀÇ CD20xCD3 ÀÌÁß Æ¯ÀÌÇ×ü ·é¼ö...
¾îÀ±È£ ±âÀÚ
'ÀÓ»ó½ÇÆÐ ¾à¹° ÀçȰ¿ë'...AZ, ½ÅÀå º´¿ë¿ä¹ý¼ È¿°ú È®ÀÎ
2023-11-07 05:50:30
[µ¥Àϸ®ÆÊ=¼ÕÇü¹Î ±âÀÚ] ¾Æ½ºÆ®¶óÁ¦³×Ä«°¡ SGLT-2 ¾ïÁ¦Á¦ °è¿ ´ç´¢º´ Ä¡·áÁ¦ Æ÷½Ã°¡(´ÙÆÄ±Û¸®Ç÷ÎÁø)¿Í °ú°Å Ç×¾ÏÁ¦·Î °³¹ßÇß´ø Áöº¸ÅÙźÀ» º´¿ëÇØ ¸¸¼º½ÅÀåÁúȯ(CKD)...
¼ÕÇü¹Î ±âÀÚ
´ç´¢¡¤ºñ¸¸ ÀÌ¾î ½ÅÀåÁúȯµµ È¿°ú...ÁøÈÇÏ´Â GLP-1 ½Å¾à
2023-11-06 12:10:53
[µ¥Àϸ®ÆÊ=¼ÕÇü¹Î ±âÀÚ] ´ç´¢º´ Ä¡·áÁ¦·Î Çã°¡¹ÞÀº GLP-1 ¼ö¿ëü ÀÛ¿ëÁ¦(ÀÌÇÏ GLP-1 Á¦Á¦)°¡ ºñ¸¸°ú ½ÅÀåÁúȯ »Ó ¾Æ´Ï¶ó ºñ¾ËÄڿüºÁö¹æ°£¿°(NASH), Ä¡¸Å µîÀ¸·Î ¿µ¿ª ...
¼ÕÇü¹Î ±âÀÚ
Áö¾ÆÀÌÀ̳뺣À̼Ç, ¸é¿ªÇ×¾ÏÇÐȸ¼ ºòÆÄ¸¶¿Í ±â¼úÀÌÀü ³íÀÇ
2023-11-06 10:00:05
[µ¥Àϸ®ÆÊ=³ëº´Ã¶ ±âÀÚ] Áö¾ÆÀÌÀ̳뺣À̼ÇÀº ¹Ì±¹ ¸é¿ªÇ×¾ÏÇÐȸ(Society for Immunotherapy of Cancer 2023, ÀÌÇÏ SITC 2023)¿¡¼ ¡®¸é¿ªÇ×¾ÏÁ¦ ³»¼º ±Øº¹¡¯ °¡´É¼º...
³ëº´Ã¶ ±âÀÚ
1
2
3
4
5
6
7
8
9
10
>
ä¿ë
¼Óº¸
ÆÊ¼îÇθô
ÀǾàǰ¸ô
Çコ¿ëǰ¸ô
±âŸ»óǰ¸ô
Àϼº½Å¾à
¸ÞµðÄ«ÄÚ¸®¾Æ
¿¥¿¡ÇÁ¾¾
À¯´Ï¸Þµå
¶ó¿ÂÆÄ¸¶
Çdzª¿ÂÁ¤
¸ÞµðÄ«ÄÚ¸®¾Æ
ÃÊÀÓ°è¾ËƼÁö
Àϼº½Å¾à
ÇÃ·ç¾ÆµåÄõµå
À¯´Ï¸ÞµåÁ¦¾à
À¯´Ï¼¾Å¸¾×
À¯´Ï¸ÞµåÁ¦¾à
¸ÞµðÆÊ¸ô
¸ÞµðÄ®Çö´ë
¸¶´õ½ºÁ¦¾à
À¯´Ï¸ÞµåÁ¦¾à
À¯´Ïµ§Å»¿ÃÄɾîÄ¡¾à
¸¶´õ½ºÁ¦¾à
ÄÜÆ¼600
¼¿·ÐÅØ
Èĸ¨
¿¥¿¡ÇÁ¾¾
¾Æ·Î´Ï¾Æ´Ü¹éÁú¹Ù
´õÆÊ¾ÆÀÌÁ¶¾Æ
ưưŰÁî
ÈÞº£À̽º
KnH¸ÞµðÅØ
°æ¹æ½Å¾à
¸Þµð¶óÀÌÇÁ
ÂøÇѳª¹«ÀÎÅ׸®¾î
³»¼Õ¾ÈÀÇ ¾à±¹
´ÚÅÍ¾ØÆÊ
µ¿ÀÇÇѹæ
¾à±¹°æ¿µ¼¼¹Ì³ª ÈÞº£À̽º
µ¿ÀÇÇѹæÃ¼ÀÎ
°æ¹æ½Å¾à
°æ¿Á°í
¾à±¹ÀÎÅ׸®¾î
¾à»ç´Ô ÀÔ¼Ò¹®
¾à»ç¸¦ À§ÇÑ ¾à±¹ Ç÷§Æû
¿¥¿¡ÇÁ¾¾
¿¥Å©¸°
¾à»ç ½Å¿ë´ëÃâ
¾Ë¸² ¡¤ °øÇ¥
±³À° ¡¤ °ÁÂ
¾à±¹»ó´ã¼Ò
Á¢¼ö ¡¤ ¹®ÀÇ
¾Ë¸²
[3RÄÚ¸®¾Æ]ICT ±ÔÁ¦»÷µå¹Ú½º ½ÇÁõ Ư·Ê ½ÂÀÎ!! ¼³Ä¡ ¹× ...
¾Ë¸²
[TVÆÊµµ¶ó]¾çÄ¡¿Í ÀÕ¸öÁúȯ Ä¡·á±îÁö Çѹø¿¡!
¾Ë¸²
¶ó¿ÂÆÄ¸¶,Å»¸ðº¸Á¶Á¦ ÆÇ½Ã¿Âĸ½¶ Ãâ½Ã!
¾Ë¸²
Á¦ 5ȸ ´ÚÅÍ¾ØÆÊ Ã¢¾÷¼¼¹Ì³ª 11.26(ÀÏ) ½Åû GO¢º
¾Ë¸²
½ºÆ®·¾½Ç ½Å±Ô 📺TV±¤°í ·Ðαâ³ä EVENT¢º
¾Ë¸²
[TVÆÊµµ¶ó]°Ç°ÇÑ ´ÙÀÌ¾îÆ® ¾Ë·éÁ¤
¾Ë¸²
ºñŸºñÄɾîÁ¤ ½ÅÁ¦Ç° Ãâ½Ã EVENT! Go¢º
D-30
[ÆÊŬ·¡½º]Àü°Á ¹«Á¦ÇÑ ½Ãû! (Ç×½ÃÁ¢¼ö) ( ~12.31 )
D-30
[ÆÊ½ºÅ͵ð]ij³ª´Ù ¾à»ç ÀÚ°ÝÁõ[Ç×½ÃÁ¢¼ö] ( ~12.31 )
D-1
ÅäÅ©ÄܼƮ - »ó´ã¿ªÀü💬 (12/3) ( ~12.02 )
¹ý·ü»ó´ã
»çÀüÁ¶Á¦¿¡ ´ëÇÑ Ã³¹ú
¼¼¹«¡¤³ë¹«
±Ù·Î°è¾à¼ ÀÛ¼ºÇÏÁö ¾ÊÀº ÀÏ¿ëÁ÷±Ù·ÎÀÚ
¾à»ç´ëÃâ
ºÀÁ÷¾à»ç ´ëÃâ ÈÄ ÅðÁ÷½Ã
¼¼¹«»ó´ã
¾à±¹¾çµµ¾ç¼ö½Ã ÀÏ¹Ý¾à °è»ê?
¾à±¹°æ¿µ°ú â¾÷
Ãþ¾à±¹¿¡¼ ¸Å¾àÀº ¾ó¸¶±îÁö °¡´ÉÇѰ¡¿ä?
ÆùºÎ½º´ëºÎ
3°³ ¾à±¹¿¡ ÀçÁ÷ ÁßÀÎ ±Ù¹« ¾à»ç ´ëÃâ ¹®ÀÇ
¾à±¹ÈÀåǰ
ư»ìÅ©¸² ¹®ÀÇ
¾à»ç½Å¿ë´ëÃâ
ÀÌÀ²À» Á» ³·Ãß´Â ¹æ¹ý¹®ÀÇ
±³À° °Á ¹× ¾Ë¸² ±¤°í ¾È³» ÆäÀÌÁö
¿¬¼ö, ±³À°, ¼¼¹Ì³ª, Çмú°Á ¹× ±â¾÷±³À°, ¸ðÁý
°øÇ¥, Åä·Ðȸ, ÀǾàǰ º¯°æ ¾È³» ¹× °¢Á¾ Çà»ç
¾Ë¸² ±¤°í¸¦ ÇØµå¸³´Ï´Ù.
(Á¢¼ö ¹®ÀÇ ¹Ù·Î°¡±â)
¿À´ÃÀÇ
ÇÖ´º½º
1
1¿ù 3õ¿© ǰ¸ñ ¾à°¡ÀÎÇÏ...¶Ç ½ÃÀ۵Ǵ Á¤»êÀüÀï
2
GMP À§¹Ý¿¡ 2700¾ï Áõ¹ß À§±â...Á¦¾à, ±äÀå°¨ È®»ê
3
¹ÙÀÌ¿À±â¾÷ IPO°ø¸ð¾× 2³â»õ 96%¡é¡¦»óÀå°Ç¼ö ¹ÝÅ丷
4
ºñ´ë¸éÁø·á, ´ëÆø È®´ë¡¦ÈÞÀÏ¡¤¾ß°£¿£ ÃÊÁø Àü¸é Çã¿ë
5
µà¶ôÄÀÌÁö, ¾àÆòÀ§ ½ÉÀÇ ÀÌÀü °ø´Ü°ú ¼ö·®Çù»ó ¿Ï·á
6
"Á¦¾à ¿µ¾÷¸¶ÄÉÆÃ Ãâ½Å CSO Àü¹® ¼¼¹«»çÁÒ"
7
À¯ÀüÀÚ°¡À§ »ó¾÷È °¡½ÃÈ...ÁÖ¸ñ¹Þ´Â K-¹ÙÀÌ¿À±â¾÷µé
8
"ÈÞÅØ½º óºÐ °í¹Î ¸¹¾ÒÁö¸¸...Áß´ëÇÑ À§¹Ý½Ã ¾öÁß´ëó"
9
°úÀ層°í´Â ±âº»...Àα⠾à»ç »çÄªÇØ °Ç°»ó´ã±îÁö
10
Çѱ¹¾Æ½ºÆ®¶óÁ¦³×Ä«, Àü¼¼È¯ ½ÅÀÓ ´ëÇ¥ÀÌ»ç ¼±ÀÓ